Palpitations: Differential Diagnosis and Management

Differential Diagnosis

The American Heart Association suggests that the differential diagnosis of palpitations fundamentally depends on whether the rhythm is regular or irregular, as this distinction changes the entire diagnostic approach 1
Paroxysmal supraventricular tachycardia (PSVT) with sudden onset and termination most commonly indicates AVNRT or AVRT, particularly in younger patients, according to the American College of Cardiology 1, 2
Sinus tachycardia accelerates and terminates gradually, often triggered by stressors like infection, volume loss, caffeine, nicotine, or medications, as noted by the American Heart Association 1
Ventricular tachycardia presents with sudden onset/offset and may be associated with presyncope or syncope, as indicated by the European Heart Journal 3
Atrial flutter with regular ventricular response is a type of regular palpitation, as described by the American Heart Association 4

Diagnostic Approach

The American College of Cardiology recommends obtaining a 12-lead ECG immediately to identify the rhythm, look for pre-excitation, and determine if the tachycardia is regular or irregular 2
Pattern characterization, including number of episodes, duration, frequency, mode of onset, and triggers, is crucial in diagnosing palpitations, as suggested by the American Heart Association 1, 2
Regular vs irregular rhythm distinction is the most important factor in diagnosing palpitations, according to the American Heart Association 1, 2
Sudden onset/termination suggests AVNRT or AVRT, as indicated by the American College of Cardiology 1
Response to vagal maneuvers, such as termination, suggests re-entrant tachycardia involving AV nodal tissue, as noted by the American Heart Association 1, 2
Associated symptoms, including syncope, presyncope, chest discomfort, dyspnea, or polyuria, are important in diagnosing palpitations, as described by the European Heart Journal 1, 3

Management

The American College of Cardiology recommends immediate management based on clinical presentation, including hemodynamically unstable patients and stable patients without ECG documentation 5
Hemodynamically unstable patients should undergo DC cardioversion, as indicated by the American College of Cardiology 5
Stable patients without ECG documentation should be taught vagal maneuvers and may be prescribed beta-blockers empirically, as suggested by the American College of Cardiology 5
The American College of Cardiology recommends referring patients with Wolff-Parkinson-White syndrome, wide complex tachycardia of unknown origin, severe symptoms during palpitations, drug resistance or intolerance, and patients desiring to be free of drug therapy to a specialist 5, 2

Special Considerations

Tachycardia-mediated cardiomyopathy can occur in patients with SVT that persists for weeks to months with fast ventricular response, emphasizing the importance of timely diagnosis and treatment, as noted by the American Heart Association 1, 2
Family screening is crucial in patients with sudden arrhythmic death syndrome, including first-degree relatives of sudden death victims, as indicated by the European Heart Journal 3
Common pitfalls to avoid include starting class I or III antiarrhythmics empirically without documented arrhythmia, ordering comprehensive laboratory panels routinely, using ATP testing to select patients for pacing, and dismissing syncope with palpitations, as described by the American College of Cardiology and the European Heart Journal 5, 6, 7, 1, 2

Diagnostic Approach to Palpitations

Initial Clinical Assessment

The American College of Cardiology suggests that pattern characterization is crucial and must include onset and termination, duration and frequency of episodes, response to vagal maneuvers, precipitating factors, and associated symptoms, such as syncope, presyncope, chest discomfort, dyspnea, or polyuria, which occurs in approximately 15% of SVT patients 8
The American College of Cardiology recommends looking for irregular cannon A waves and irregular variation in S1 intensity during tachycardia, which strongly suggests ventricular origin 8

Immediate ECG Interpretation

The American College of Cardiology states that pre-excitation present with a history of paroxysmal regular palpitations suggests a presumptive diagnosis of AVRT, and immediate referral to electrophysiology is recommended 8
The American College of Cardiology suggests that pre-excitation with irregular palpitations strongly suggests atrial fibrillation with an accessory pathway, requiring immediate electrophysiological evaluation due to the risk of sudden death 8

Echocardiography Indications

The American College of Cardiology recommends ordering echocardiography when there is documented sustained SVT to exclude structural heart disease, which usually cannot be detected by physical examination alone 8
The American College of Cardiology suggests ordering echocardiography when there is clinical suspicion of structural abnormalities like valvular aortic stenosis, hypertrophic cardiomyopathy, or tachycardia-mediated cardiomyopathy 8

Mandatory Specialist Referral Criteria

The American College of Cardiology recommends referring immediately to cardiac electrophysiology for all patients with Wolff-Parkinson-White syndrome due to the potential for lethal arrhythmias 8
The American College of Cardiology suggests referring immediately to cardiac electrophysiology for patients with severe symptoms during palpitations, such as syncope or dyspnea 8
The American College of Cardiology recommends referring immediately to cardiac electrophysiology for patients with narrow complex tachycardia with drug resistance or intolerance 8

Critical Pitfalls to Avoid

The American College of Cardiology suggests not relying on automatic ECG analysis systems, as they are unreliable and commonly suggest incorrect diagnoses 8

Palpitations Diagnosis and Monitoring

Ambulatory ECG Monitoring Strategy

The American College of Cardiology recommends 24-48 hour Holter monitoring for patients with daily palpitations, as indicated by studies published in the Journal of the American College of Cardiology in 2024 and 2020 9, 10
For patients with hypertrophic cardiomyopathy, the American College of Cardiology suggests 24-48 hour ambulatory monitoring every 1-2 years as part of periodic follow-up, with extended monitoring recommended for those with additional AF risk factors 9, 10

Special Considerations

The American College of Cardiology advises that patients with hypertrophic cardiomyopathy require extended monitoring if they have additional AF risk factors, such as left atrial dilatation, advanced age, or NYHA class III-IV heart failure 9, 10

Ambulatory ECG Monitoring for Palpitations

Preparation and Initial Steps

The American College of Cardiology recommends stopping all caffeine, alcohol, nicotine, and reviewing medications that may trigger arrhythmias in patients with palpitations 11
Assessing for recreational drug use is also recommended by the American College of Cardiology in patients with palpitations 11
Instructing the patient in Valsalva maneuver and carotid massage to perform during episodes is suggested by the American College of Cardiology 11

Monitoring Strategies

The American College of Cardiology guidelines specifically recommend event or loop recorders for "less frequent arrhythmias" rather than daily Holter monitoring 11
For symptoms occurring several times per week, event recorders have superior diagnostic yield and are more cost-effective compared to Holter monitoring, as recommended by the American College of Cardiology 11
Reserve Holter monitoring only for patients with daily palpitations, as suggested by the American College of Cardiology 11

Medical Therapy Considerations

The American College of Cardiology recommends that a beta-blocker may be prescribed empirically while awaiting monitoring results, but only after excluding significant bradycardia (<50 bpm) 11
The American College of Cardiology advises against starting Class I or III antiarrhythmic drugs without documented arrhythmia due to significant proarrhythmic risk 11

Additional Workup and Referral

The American College of Cardiology recommends ordering echocardiography if sustained SVT is documented or if there is clinical suspicion of structural heart disease 11
Consider exercise testing if palpitations are clearly triggered by exertion, as suggested by the American College of Cardiology 11
Refer immediately to cardiac electrophysiology if wide complex tachycardia is documented on any rhythm strip, as recommended by the American College of Cardiology 11
Consider an implantable loop recorder if symptoms are less than 2 episodes per month and associated with severe symptoms or hemodynamic instability, as suggested by the American College of Cardiology and the European Heart Journal 11, 12

Diagnostic Evaluation

Regular rhythm with sudden onset/offset suggests AVNRT or AVRT, as indicated by the American College of Cardiology 11
The European Heart Journal suggests considering an implantable loop recorder if external monitoring is non-diagnostic but clinical suspicion remains high 12

Palpitations Diagnosis and Management

Cardiac Arrhythmias

Atrial fibrillation presents with irregular palpitations and may be paroxysmal, persistent, or permanent, according to the American Heart Association 13
Premature atrial contractions are common and often benign, presenting as skipped beats or extra beats, as noted by the European Heart Society 14
Wolff-Parkinson-White syndrome with pre-excitation carries a risk of sudden death and requires immediate electrophysiology referral, as recommended by the American College of Cardiology 15
Marked sinus bradycardia (<40 bpm) or sinus pauses >3 seconds can cause symptomatic palpitations, according to the European Heart Society 14

Non-Arrhythmic Cardiac Causes

Hypertrophic cardiomyopathy may present with palpitations and requires echocardiographic evaluation, as suggested by the European Heart Society 16
Dehydration leading to compensatory tachycardia is a potential cause of palpitations, as noted by the European Heart Society 16

Non-Cardiac Causes

Hyperthyroidism is a common non-cardiac cause that must be excluded with thyroid function tests, according to the American Heart Association 13
Alcohol can trigger arrhythmias, particularly atrial fibrillation, as reported by the American Heart Association 13

Palpitations Diagnosis and Management

Patient Assessment and Monitoring

The American Heart Association suggests that wide complex tachycardia may represent VT or SVT with aberrancy; look for AV dissociation or fusion complexes diagnostic of VT 17
The American College of Cardiology recommends that monitoring must continue until symptoms occur while wearing the device—non-diagnostic monitoring should not be considered conclusive 18
For patients with hypertrophic cardiomyopathy, 24-48 hour ambulatory monitoring every 1-2 years is recommended as part of periodic follow-up, with extended monitoring if additional AF risk factors are present 18

Special Considerations

Patients with symptoms such as syncope, presyncope, chest pain, dyspnea, or polyuria (which occurs in ~15% of SVT patients) should be evaluated further 17

Management of Documented Supraventricular Tachycardia (SVT)

Introduction to SVT Management

The American College of Cardiology recommends that patients with documented SVT, despite normal structural evaluation, require referral to a cardiac electrophysiologist for consideration of catheter ablation 19
The American College of Cardiology states that documented SVT episodes are real and require treatment, regardless of whether all symptomatic episodes correlate with arrhythmia 19

Understanding SVT Symptoms

Approximately 15% of SVT patients experience syncope, and symptoms vary significantly with individual patient perceptions 20, 21
The American College of Cardiology notes that vagal maneuver response confirms re-entrant tachycardia involving AV nodal tissue (AVNRT or AVRT) 20, 21

Diagnostic Considerations

The American Heart Association suggests that documented SVT on event monitoring requires definitive management 19
The American College of Cardiology recommends that a young patient with documented SVT and a normal structural heart is a good candidate for curative therapy rather than lifelong medication 19

Treatment Options

The American College of Cardiology states that beta-blocker therapy may be prescribed empirically after excluding significant bradycardia (<50 bpm) 19
The American Heart Association notes that catheter ablation has a high success rate, with <5% recurrence and <1% risk of heart block, and is potentially curative 20, 21

Monitoring and Referral

The American College of Cardiology recommends documenting response to vagal maneuvers during symptomatic episodes to help confirm diagnosis 20, 21
The American Heart Association suggests monitoring for concerning symptoms: syncope, presyncope, or severe dyspnea warrant urgent evaluation 22

Diagnostic Approach for Intermittent Palpitations

Extended Cardiac Monitoring and Laboratory Testing

For symptoms less than twice monthly with severe features, consider an implantable loop recorder, as recommended by the American College of Cardiology 23
Reassess renal function (creatinine, GFR) as baseline for medication decisions, following guidelines from the European Society of Cardiology 24

Special Considerations for Hypertension and Decreased GFR

Medication selection must account for renal function, with appropriate dosing adjustments, as suggested by the European Society of Cardiology 24
Optimize blood pressure control to reduce arrhythmia risk, and monitor for electrolyte abnormalities, particularly potassium, which affects arrhythmia risk 24

Exercise Testing and Arrhythmia Evaluation

Exercise stress testing can detect exercise-induced arrhythmias, assess chronotropic response and blood pressure behavior, and identify ischemia-related conduction disorders, as recommended by the American College of Cardiology 23 and the American Heart Association 25

Management of Palpitations with Thyroid Dysfunction

Diagnosis and Treatment

The American College of Cardiology recommends that patients with overt hyperthyroidism, which is the primary cause of palpitations, must be treated urgently, and restoration of euthyroid state is the primary goal, as this usually results in spontaneous resolution of arrhythmias 26
Atrial fibrillation occurs in 5-15% of hyperthyroid patients and is more common in those over 60 years, according to the American College of Cardiology 26
The American College of Cardiology suggests that beta-blockers are the preferred initial agent for rate control in hyperthyroidism, but use with extreme caution, and if beta-blockers are contraindicated or cardiac function is impaired, use a nondihydropyridine calcium channel blocker instead 26
The American College of Cardiology recommends assessing stroke risk using CHA₂DS₂-VASc score if atrial fibrillation is documented, and base anticoagulation decisions on CHA₂DS₂-VASc risk factors rather than thyroid status alone 26
Most patients with thyrotoxicosis-induced arrhythmias will spontaneously convert to sinus rhythm once euthyroid, according to the American College of Cardiology 26
The American College of Cardiology advises against abrupt beta-blocker withdrawal once started, as this can precipitate thyroid storm in hyperthyroid patients 26

Risk Stratification and Management of Palpitations

High‑Risk Features Requiring Immediate Evaluation

The American College of Cardiology advises that the presence of syncope or presyncope, chest pain or dyspnea, palpitations occurring with exertion in patients with known structural heart disease (e.g., hypertrophic cardiomyopathy or aortic stenosis), or documentation of a wide‑complex tachycardia on any rhythm strip constitutes a high‑risk presentation that mandates urgent evaluation for potentially life‑threatening arrhythmias. Evidence level: not specified 27

Moderate‑Risk Features Requiring Prompt Outpatient Evaluation

According to the American College of Cardiology, the following moderate‑risk criteria should prompt timely outpatient work‑up: (1) frequent episodes (daily to weekly) that are not hemodynamically compromising, (2) palpitations that interfere with daily activities or work performance, (3) any underlying structural heart disease even when symptoms are mild, and (4) pre‑excitation patterns on ECG in patients with a history of paroxysmal palpitations suggestive of AV‑reentrant tachycardia. Evidence level: not specified 27

Athlete‑Specific Conduction Findings

The European Society of Cardiology notes that first‑degree atrioventricular (AV) block or Mobitz type I block that resolves during exercise does not require therapy in asymptomatic athletes without structural heart disease. Evidence level: not specified 28
The same guidance states that Mobitz type II or third‑degree AV block in athletes warrants comprehensive evaluation and implantation of a pacemaker when the patient is symptomatic or when structural cardiac disease is present. Evidence level: not specified 28

Assessment and Initial Evaluation of Palpitations

History Taking

Clinicians should systematically record the frequency, typical duration, and total number of palpitations episodes to guide further work‑up. 29
A thorough history must query alcohol, caffeine, sleep deprivation, emotional stress, exercise, and large meals as common precipitants of palpitations. [30] [31]
Patients with supraventricular tachycardia frequently report polyuria (≈15 % prevalence), highlighting the need to ask about urinary symptoms. 30

Physical Examination

Irregular peripheral pulse and jugular venous pulsations are key bedside clues that point toward atrial fibrillation. [30] [29]
Variability in the intensity of the first heart sound or loss of a previously audible fourth heart sound also supports a diagnosis of atrial fibrillation. [30] [31]
A focused exam should assess for valvular disease, signs of heart failure, and other structural cardiac abnormalities that may underlie palpitations. [30] [31]

Mandatory Initial Diagnostic Tests

A 12‑lead electrocardiogram must be obtained in every patient to identify baseline rhythm, pre‑excitation patterns, and conduction abnormalities. 29
Baseline laboratory evaluation should include a complete blood count, serum electrolytes (especially potassium), renal function, and hepatic function tests to uncover metabolic contributors. 29
Chest radiography is recommended to evaluate for pulmonary pathology and assess pulmonary vasculature that could provoke palpitations. 29
Transthoracic echocardiography is indicated in any patient with documented atrial fibrillation to assess left atrial size, ventricular dimensions, wall thickness, systolic function, and to exclude valvular or pericardial disease. 29

Management of Short‑Run SVT Detected on Zio Monitoring

Initial Assessment & Risk Stratification

Symptom correlation and pre‑excitation determine management pathway – In patients with five brief SVT runs, if they are asymptomatic, have a structurally normal heart, and no pre‑excitation on the baseline ECG, reassurance with lifestyle modification and optional beta‑blocker therapy is appropriate; symptomatic patients or those who desire freedom from recurrences should be referred for catheter ablation. 32
Baseline QRS morphology should be compared with tachycardia QRS to identify aberrancy and guide further work‑up. 33

Diagnostic Work‑up

Vagal maneuvers (Valsalva) are preferred over carotid sinus massage because they are safer and more effective, particularly in older adults. Successful termination supports a re‑entrant AV‑node–dependent tachycardia (AVNRT/AVRT). 32

Management of Asymptomatic or Minimally Symptomatic Patients

Empiric beta‑blocker therapy may be initiated after confirming the absence of significant bradycardia (resting rate ≥ 50 bpm). Metoprolol or atenolol are reasonable first‑line agents for suppressing SVT episodes. 32

Management of Symptomatic Patients

Medical therapy while arranging electrophysiology referral – Initiate a beta‑blocker (metoprolol, atenolol) or a non‑dihydropyridine calcium‑channel blocker (diltiazem, verapamil). Verapamil terminates acute SVT in ~93 % of cases and is effective for chronic suppression, though beta‑blockers are often preferred for long‑term use. 34
Digoxin should be avoided as first‑line therapy because it is less effective than beta‑blockers or calcium‑channel blockers and carries a higher toxicity risk, especially in patients with renal impairment. [32][34]

Referral & Procedural Considerations

Mandatory referral criteria for electrophysiology evaluation include:
Catheter ablation outcomes – For AVNRT, catheter ablation achieves >95 % acute success, with <5 % recurrence and <1 % risk of complete heart block requiring permanent pacing. This high efficacy supports offering ablation to suitable young patients with normal cardiac structure. 32

Special Pitfalls

Do not empirically start Class Ic (flecainide, propafenone) or Class III (sotalol, amiodarone) antiarrhythmics without documented sustained arrhythmia and exclusion of structural heart disease, due to a substantial pro‑arrhythmic risk. 32